Structured whole-body MRI highlights clinically relevant disease pattern changes in relapsed/refractory multiple myeloma
Martin Grözinger(German Cancer Research Center), Lukas John(University of Hohenheim), Lilli Sophie Sester(Heidelberg University), Marina Hajiyianni(Heidelberg University), Alexandra M. Poos(German Cancer Research Center), Jan Frenking(German Cancer Research Center), Heidi Thierjung(German Cancer Research Center), M. S. Raab(German Cancer Research Center), Christian Michel(Philipps University of Marburg), Niels Weinhold(German Cancer Research Center), E K(Heidelberg University), Stefan Delorme(German Cancer Research Center), Kaya Veelken(Heidelberg University), Sandra Sauer(Heidelberg University), Theresia Weber(University of Applied Sciences Mainz), Markus Wennmann(German Cancer Research Center), Dorothee Kaudewitz(Innsbruck Medical University), M Schlanke(German Cancer Research Center), Heinz-Peter Schlemmer(German Cancer Research Center), Hartmut Goldschmidt(Heidelberg University), Carsten Müller-Tidow(Heidelberg University), Sam Sedaghat(Heidelberg University), Jana Gröne(German Cancer Research Center), Stella Erdmann(Zimmer Biomet (Netherlands))
Cited by 0
Related Papers
Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing
|Nature Communications|2017|418
Circulating MicroRNAs as Novel Biomarkers for Platelet Activation
|Circulation Research|2013|396
Association of MicroRNAs and YRNAs With Platelet Function
|Circulation Research|2015|204
Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single‐cell transcriptomics
|Nature Communications|2021|141
Graded Cardiac Response Criteria for Patients With Systemic Light Chain Amyloidosis
|Journal of Clinical Oncology|2022|91